
Shield Therapeutics shares jump 11% as losses narrow and profitability target for 2026 is confirmed
Shield Therapeutics PLC saw its shares rise 11% after reporting a significant reduction in half-year losses and reaffirming its goal to achieve operating profitability in 2026. The company's revenue increased 42% to $30.4 million, driven by US sales ...


